JPMorgan Chase & Co’s Checkpoint Therapeutics CKPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1
| Closed | -$4 | – | 6226 |
|
|
2025
Q1 | $4 | Hold |
1
| – | – | ﹤0.01% | 6356 |
|
|
2024
Q4 | $3 | Hold |
1
| – | – | ﹤0.01% | 6291 |
|
|
2024
Q3 | $2 | Hold |
1
| – | – | ﹤0.01% | 6280 |
|
|
2024
Q2 | $2 | Hold |
1
| – | – | ﹤0.01% | 6250 |
|
|
2024
Q1 | $2 | Hold |
1
| – | – | ﹤0.01% | 6294 |
|
|
2023
Q4 | $2 | Sell |
1
-38
| -97% | -$76 | ﹤0.01% | 6429 |
|
|
2023
Q3 | $66 | Buy |
39
+38
| +3,800% | +$64 | ﹤0.01% | 5997 |
|
|
2023
Q2 | $2 | Hold |
1
| – | – | ﹤0.01% | 5943 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 5829 |
|
|
2022
Q4 | $0 | Sell |
1
-1
| -50% | – | ﹤0.01% | 5606 |
|
|
2022
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 5545 |
|
|
2022
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 5614 |
|
|
2022
Q1 | $0 | Sell |
2
-1,396
| -100% | – | ﹤0.01% | 5743 |
|
|
2021
Q4 | $43K | Buy |
1,398
+1,396
| +69,800% | +$42.9K | ﹤0.01% | 5124 |
|
|
2021
Q3 | $0 | Sell |
2
-8,628
| -100% | – | ﹤0.01% | 5534 |
|
|
2021
Q2 | $254K | Sell |
8,630
-2,530
| -23% | -$74.5K | ﹤0.01% | 4370 |
|
|
2021
Q1 | $350K | Sell |
11,160
-2,658
| -19% | -$83.4K | ﹤0.01% | 4222 |
|
|
2020
Q4 | $366K | Buy |
13,818
+10,830
| +362% | +$287K | ﹤0.01% | 3911 |
|
|
2020
Q3 | $83K | Sell |
2,988
-1,095
| -27% | -$30.4K | ﹤0.01% | 4129 |
|
|
2020
Q2 | $81K | Buy |
4,083
+3,300
| +421% | +$65.5K | ﹤0.01% | 4040 |
|
|
2020
Q1 | $12K | Sell |
783
-4,673
| -86% | -$71.6K | ﹤0.01% | 4431 |
|
|
2019
Q4 | $94K | Buy |
5,456
+4,654
| +580% | +$80.2K | ﹤0.01% | 4048 |
|
|
2019
Q3 | $20K | Buy |
802
+169
| +27% | +$4.21K | ﹤0.01% | 4481 |
|
|
2019
Q2 | $21K | Buy |
+633
| New | +$21K | ﹤0.01% | 4502 |
|